Drug-induced tremor
Methodology & AI Transparency ⓘ
Drug-induced tremor Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: For patients presenting with Drug-induced tremor (ICD-10-CM G25.1), Neurology, Stroke & Movement Disorders protocols prioritize vascular stroke risk in Drug-induced tremor (G25.1: stratification) paired with baseline and interval Serum Vitamin B12 in Drug-induced tremor (G25.1: & Methylmalonic Acid) assessment.
- 2 Real-world patient consensus: Federal ICD-10-CM code G25.1 categorizes Drug-induced tremor under Neurology, Stroke & Movement Disorders.
- 3 Typical cash cost range: Workup highlights for Drug-induced tremor (G25.1): vascular stroke risk in Drug-induced tremor (G25.1: stratification).
- 4 Top reported side effects / signs: Key Brain & Neurology biomarkers for Drug-induced tremor (G25.1): Serum Vitamin B12 in Drug-induced tremor (G25.1: & Methylmalonic Acid) & Carotid Duplex / in Drug-induced tremor (G25.1: Cerebral Perfusion) (No hemodynamically significant stenosis (G25.1)).
Ask our AI Specialists anything about Drug-induced tremor
What Is Drug-induced tremor?
For patients presenting with Drug-induced tremor (ICD-10-CM G25.1), Neurology, Stroke & Movement Disorders protocols prioritize vascular stroke risk in Drug-induced tremor (G25.1: stratification) paired with baseline and interval Serum Vitamin B12 in Drug-induced tremor (G25.1: & Methylmalonic Acid) assessment.
Pathophysiology, Underlying Causes & Clinical Presentation
Biological expression of Drug-induced tremor (G25.1, Brain & Neurology) reflects cerebrovascular ischemia [Drug-induced tremor G25.1]. longitudinal control is benchmarked via Serum Vitamin B12 in Drug-induced tremor (G25.1: & Methylmalonic Acid).
Common Symptoms & Clinical Signs
- • Presentation of Drug-induced tremor (G25.1): focal motor weakness, in Drug-induced tremor (G25.1: resting or action)
- • Secondary Drug-induced tremor clinical sign: episodic vertigo, imbalance, in Drug-induced tremor (G25.1: coordination drift, or)
- • Symptom flares in Drug-induced tremor correlating with Serum Vitamin B12 in Drug-induced tremor (G25.1: & Methylmalonic Acid) deviation outside B12 > 500 pg/mL; MMA < 240 nmol/L (G25.1)
- • Functional brain & neurology impact requiring vascular stroke risk in Drug-induced tremor (G25.1: stratification) evaluation (G25.1)
Drug-induced tremor Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | G25.1 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Neurology, Stroke & Movement Disorders | NLM Clinical Tables |
| Diagnostic / Lab Marker: Serum Vitamin B12 in Drug-induced tremor (G25.1: & Methylmalonic Acid) | B12 > 500 pg/mL; MMA < 240 nmol/L (G25.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Carotid Duplex / in Drug-induced tremor (G25.1: Cerebral Perfusion) | No hemodynamically significant stenosis (G25.1) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: HbA1c & Blood in Drug-induced tremor (G25.1: Pressure Neuro-Targets) | BP < 120/75 mmHg; HbA1c < 5.7% (G25.1) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Drug-induced tremor
Treatment selection for Drug-induced tremor depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Drug-induced tremor)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Efficacy and tolerability of antidepressant drugs in treatment of depression in: What a 6,949-Participant Study Found A total of 33 RCTs were included in 32 articles, involving 6949 patients. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences • 2022-08-01 • Meta-Analysis | N = 6,949 | 99/100 | PMID 37202104 ↗ |
| New Insights on Is metformin still the most efficacious first-line oral hypoglycaemic drug in: What a 33,830-Participant Study Found This meta-analysis showed that repaglinide and metformin would be the most efficacious oral drugs for first-line single-drug treatment of T2DM. Obesity reviews : an official journal of the International Association for the Study of Obesity • 2019-01-15 • Meta-Analysis | N = 33,830 | 99/100 | PMID 30230172 ↗ |
| New Insights on Benefits and safety of anti-prediabetic drugs in patients with prediabetes: a: What a 16,610-Participant Study Found Among all the included interventions, GLP-1RAs, GIP/GLP-1RAs, and TZDs demonstrated favorable anti-prediabetic efficacy and acceptable safety. BMC medicine • 2026-02-19 • Meta-Analysis | N = 16,610 | 99/100 | PMID 41715123 ↗ |
| New Insights on Comparative efficacy and acceptability of anxiolytic drugs for the treatment of: What a 28,637-Participant Study Found This network meta-analysis provides a unique comparison of the efficacy and acceptability of anxiolytics. European archives of psychiatry and clinical neuroscience • 2026-06-15 • Meta-Analysis | N = 28,637 | 99/100 | PMID 40788541 ↗ |
| New Insights on Efficacy of bictegravir/emtricitabine/tenofovir alafenamide versus: What a 1,306-Participant Study Found Participants with suboptimal (<85%) staying on track with medication to B/F/TAF maintained high levels of VS, whereas suboptimal DTG + 2 NRTI staying on track with medication was associated with lower VS. The Journal of antimicrobial chemotherapy • 2025-01-03 • Phase III Randomized Trial | N = 1,306 | 96/100 | PMID 39556192 ↗ |
Drug-induced tremor Patient Community & “People Like Me” Threads
Filter Drug-induced tremor community threads and patient logs by age, biological sex, dosage, and treatment duration.